Moricizine
59 interactions 5 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Ketoconazole Topical
Digoxin
Metronidazole
Metronidazole Vaginal
Metronidazole Topical
Diazepam Rectal
Contraindicated
Moricizine Ketoconazole Topical Extina® Foam Increased CYP3A4 substrate exposure and an increased risk of QT interval prolongation DetailsMajor
Moricizine Acetaminophen And Codeine Capital® & Codeine Explained An increased risk of respiratory and CNS depression Details Moricizine Amitriptyline Elavil Explained An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Moricizine Sertraline Explained An increased risk of QT interval prolongation Details Moricizine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation and an increased risk of CNS and respiratory depression Details Moricizine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Moricizine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Moricizine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Moricizine Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Moricizine Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Moricizine Bedaquiline Sirturo Increased risk of QT interval prolongation Details Moricizine Butorphanol Injection Butorphic Increased risk of respiratory and CNS depression Details Moricizine Butorphanol Nasal Spray Stadol® NS Increased risk of respiratory and CNS depression Details Moricizine Cetirizine Injection Aller-Tec Increased risk of CNS depression Details Moricizine Cetirizine Ophthalmic Zerviate Increased risk of CNS depression Details Moricizine Chloroquine Aralen® Increased risk of QT-interval prolongation Details Moricizine Dasatinib Phyrago An increased risk of QT interval prolongation Details Moricizine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Moricizine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Moricizine Diazepam Nasal Spray Valtoco Increased risk of CNS depression Details Moricizine Diazepam Rectal Diastat Increased risk of CNS depression Details Moricizine Digoxin Cardoxin® An increased risk of cardiotoxicity (first degree atrioventricular block, bundle branch block) Details Moricizine Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Moricizine Encorafenib Braftovi Increased risk of QT interval prolongation Details Moricizine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Moricizine Esketamine Nasal Spray Spravato Increased risk of sedation Details Moricizine Fentanyl Transdermal Patch Duragesic® Increased risk of profound sedation, respiratory depression, hypotension, coma and death Details Moricizine Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Moricizine Fostemsavir Rukobia Increased risk of torsade de pointes Details Moricizine Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Moricizine Glasdegib Daurismo Increased risk of QT interval prolongation Details Moricizine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Moricizine Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Moricizine Hydromorphone Injection Dilaudid Increased risk of respiratory and CNS depression Details Moricizine Hydromorphone Rectal available generically Increased risk of respiratory and CNS depression Details Moricizine Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Moricizine Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Moricizine Lacosamide Injection Motpoly An increased risk of CNS depression Details Moricizine Lefamulin Xenleta Increased risk of QT interval prolongation Details Moricizine Lenvatinib Lenvima Increased risk of QT-interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.